gxp-validation
(2)
QPharma and the Secret Life of a Free Sample
A drug sample may be free. Getting it into the right hands is a business of its own. QPharma has spent three decades connecting the software, people and warehouses behind that deceptively simple exchange.
Sware
Sware is a Boston-based software company that modernizes GxP validation for life sciences. Its cloud-native Res_Q platform and developer-focused GxPNext product use AI and a decade of regulated validation knowledge to automate the computer system validation (CSV) work that the FDA and other regulators require - helping pharmaceutical, biotech, medical device and CDMO teams cut validation time and cost while staying audit-ready. Formerly Boston Technology Research (BTR), the company rebranded to Sware in 2022 and has raised roughly $26-27M to date.